News
REVBW
0.0143
0.00%
0.0000
Weekly Report: what happened at REVBW last week (0422-0426)?
Weekly Report · 5d ago
Weekly Report: what happened at REVBW last week (0415-0419)?
Weekly Report · 04/22 11:38
Weekly Report: what happened at REVBW last week (0408-0412)?
Weekly Report · 04/15 11:29
Weekly Report: what happened at REVBW last week (0401-0405)?
Weekly Report · 04/08 11:33
Weekly Report: what happened at REVBW last week (0325-0329)?
Weekly Report · 04/01 11:31
Weekly Report: what happened at REVBW last week (0318-0322)?
Weekly Report · 03/25 11:34
Weekly Report: what happened at REVBW last week (0311-0315)?
Weekly Report · 03/18 11:32
Weekly Report: what happened at REVBW last week (0304-0308)?
Weekly Report · 03/11 11:28
Weekly Report: what happened at REVBW last week (0226-0301)?
Weekly Report · 03/04 11:32
Weekly Report: what happened at REVBW last week (0219-0223)?
Weekly Report · 02/26 11:46
Weekly Report: what happened at REVBW last week (0212-0216)?
Weekly Report · 02/19 11:49
Weekly Report: what happened at REVBW last week (0205-0209)?
Weekly Report · 02/12 11:36
Weekly Report: what happened at REVBW last week (0129-0202)?
Weekly Report · 02/05 11:47
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
Dow Jones Industrial Average was up 0.68% at 38,410.08. Wall Street bounced back on Thursday after a selloff in the previous session. Big Tech earnings due later in the day. Top three S&P 500 percentage gainers: Corteva, Etsy and Etsy.
Reuters · 02/01 19:01
BUZZ-U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
Wall Street rose on Thursday. Dow Jones Industrial Average was up 0.15% at 38,208.21. Top three S&P 500 percentage gainers: Corteva, Etsy, Norfolk Southern. The Federal Reserve dashed hopes for early interest rate cuts. Big Tech earnings due later in the day. CMS Energy, SunPower, Etsy are among the biggest decliners.
Reuters · 02/01 16:25
BUZZ-U.S. STOCKS ON THE MOVE-Norfolk Southern, Qorvo, Align Technology
U.S. Stock index futures rise on Thursday. Dow e-minis were up 0.12% at 38,326.25. Norfolk Southern, Qorvo, Align Technology are among the top percentage gainers. The focus is on economic data and Big Tech earnings scheduled for later in the day.
Reuters · 02/01 12:32
BUZZ-U.S. STOCKS ON THE MOVE-Sarepta, Hershey, Dollar Tree
U.S. Main stock indexes were sluggish on Monday. Dow Jones Industrial Average was up 0.03% at 38,119.63. Top three S&P 500 percentage gainers: Archer-Daniels-Midland, Hershey, Dollar Tree. Investors await the Federal Reserve's interest rate decision and big-ticket tech earnings this week.
Reuters · 01/29 18:56
BUZZ-U.S. STOCKS ON THE MOVE-Overseas Shipholding, Palisade Bio, Archer-Daniels-Midland
U.S. Main stock indexes had a sluggish start on Monday. The Dow Jones Industrial Average was down 0.04% at 38,093.44. The top three S&P 500 percentage gainers were Align Technology, Palisade Bio, Archer-Daniels-Midland. The Federal Reserve's rate decision and big-ticket tech earnings this week could set the tone.
Reuters · 01/29 15:54
Weekly Report: what happened at REVBW last week (0122-0126)?
Weekly Report · 01/29 11:33
Rvltn Bioscnc: Current report
Press release · 01/23 22:24
More
Webull provides a variety of real-time REVBW stock news. You can receive the latest news about Rvltn Bioscnc through multiple platforms. This information may help you make smarter investment decisions.
About REVBW
Revelation Biosciences, Inc. is a clinical-stage life sciences company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include Gemini-SSI, which is being developed for the prevention and treatment of surgical sit infection; Gemini-AKI, which is being developed as a potential therapy for the prevention and treatment of acute kidney injury as a result of cardiac surgery; and Gemini-CKD, which is being developed as a potential therapy for the prevention and treatment of chronic kidney disease. Stimulation of TLR4 via Gemini leads to a controlled production of varied cytokines and chemokines which modulate the activity of the innate and adaptive immune response, relative to Lipopolysaccharides (LPS).